Company Search:
Advanced Search
Sponsored Links
Suda Pharmaceuticals Ltd Company Snapshot
Suda Pharmaceuticals Ltd, formerly Suda Limited, is a drug delivery company, which is engaged in pharmaceutical development of drug delivery technology, and medical devices and consumables distribution. Its segments are Suda, Westcoast Surgical & Medical Supplies (Westcoast), Malaria Research Company (MRC) and Other. The Suda segment is engaged in research and development to create new human pharmaceutical products by combining drugs with delivery technologies. The Westcoast segment is engaged in sales and logistics operation for medical devices and consumables. The MRC segment is pharmaceutical development segment for the treatment of malaria, including ArTiMist project. ArTiMist is a sublingual spray for the treatment of Plasmodium falciparum severe pediatric malaria. Its other pipeline of products includes Zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its development stage products include orals sprays for the treatment of migraine headache and erectile dysfunction.

Sales Analysis. Sales fell dramatically in 2018: Suda Pharmaceuticals Ltd reported sales of A$428,393.00 (US$309.53 thousand) for the fiscal year ending June of 2018. This represents a sharp decrease of 94.1% versus 2017, when the company's sales were A$7.22 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Suda Pharmaceuticals Ltd
  Stock Performance Chart for Suda Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): .01
(Figures in Australian Dollars)
1 Week 30.0%   13 Weeks 44.4%  
4 Weeks 30.0%   52 Weeks -62.7%  
Suda Pharmaceuticals Ltd Key Data:
  Ticker: SUD Country: Australia
  Exchanges: FRA OTC Major Industry: Health Care Equipment & Services
    Sub Industry: Medical & Hospital Equipment
  2018 Sales 428,393
(Year Ending Jan 2019).
Employees: 44
  Currency: Australian Dollars Market Cap: 8,679,963
  Fiscal Yr Ends: June Shares Outstanding: 1,335,378,860
  Share Type: Ordinary Closely Held Shares: 169,878,322
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.